Recent News for CORV - Correvio Pharma Corp.

Date Title
Sep 16 Correvio Pharma (CORV) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow
Sep 16 56 Biggest Movers From Friday
Sep 12 Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application
Sep 4 Correvio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 3 Sell-siders like InMode in premarket analyst action
Sep 3 Correvio Announces Presentation Of Brinavess® Spectrum Data At The European Society Of Cardiology 2019 Congress
Aug 23 Key events next week - healthcare
Aug 16 Is Correvio Pharma (TSE:CORV) Using Too Much Debt?
Aug 14 Correvio Pharma Corp. (CORV) CEO Mark Corrigan on Q2 2019 Results - Earnings Call Transcript
Aug 14 Correvio Pharma misses Q2 consensus
Aug 14 Correvio Pharma EPS misses by $0.05, misses on revenue
Aug 14 Correvio Reports Second Quarter 2019 Financial Results
Aug 12 Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
Aug 8 Correvio to Report Second Quarter 2019 Financial Results
Aug 7 Correvio Closes Public Offering of 9,200,000 Common Shares
Aug 5 82 Biggest Movers From Friday
Aug 2 Correvio down 14% premarket on stock offering
Aug 2 NTAP, SQ, ANET among premarket losers
Aug 2 Correvio Announces Pricing Of Public Offering Of Common Shares
Aug 1 Correvio Announces Overnight Marketed Offering of Common Shares
Jul 26 Stocks That Managed to Breach 52-Week Lows Friday
Jul 25 U.S. FDA Accepts Correvio's Resubmitted New Drug Application For Brinavess (vernakalant)
Jun 29 Hedge Funds Have Never Been This Bullish On Correvio Pharma Corp. (CORV)
Jun 24 Correvio Resubmits Brinavess (Vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Jun 18 Correvio Announces Voting Results
Back to the Main CORV Page...